Editorial corrections and citation suggestions

What we respond to

KLOW Safe is a small editorial project. We do our best to read every message but cannot respond to every category of request. Messages we respond to:

• Editorial corrections. If you believe a claim on this site mischaracterizes a study — for example, conflates rodent and human data, misreports a dose value, or attributes a finding to the wrong author or year — please let us know. Include the page URL, the specific claim, and the citation you believe should be referenced or corrected.
• Citation suggestions. If a peer-reviewed study or regulatory document relevant to KLOW component safety has been published that we have not cited, send us the DOI or PubMed link. We prefer primary literature (PubMed, PMC, ClinicalTrials.gov, FDA, journal websites) over secondary commentary.
• Methodology questions. Questions about how we decide what counts as evidence, why a particular study is or is not on the reference list, or how we distinguish single-agent from combination data.

What we do not respond to

We cannot helpfully answer the following:

• Medical questions. This is an editorial site, not a clinic. We are not licensed to give medical advice and would not be doing you a favor by trying.
• Dosing questions. No validated human dose exists for the KLOW blend. We will not invent one in an email.
• Vendor or sourcing questions. We are not affiliated with any peptide vendor, supplier, or manufacturer. We do not recommend or evaluate vendors.
• Personal use questions. We do not coach individuals on personal use of research peptides. The blend is not approved for human consumption and we will not pretend otherwise.

Editorial contact form

Use the form below. We read every message; we cannot promise a reply to every message. The form has no medical-question field and no dosing-question field — that is deliberate.

Form is rendered by the assembler. Fields: Name (optional), Email (required), Topic (Editorial correction / Citation suggestion / Methodology question), Page URL (optional), Message (required). Submission target is a Formspree endpoint or mailto: fallback wired by the assembler. No data is stored on this site.

KLOW Safe is an independent editorial project. All content is editorial commentary on publicly available research.